World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT02043080
Date of registration: 16/01/2014
Prospective Registration: No
Primary sponsor: University of North Carolina, Chapel Hill
Public title: Optimizing Clinical Outcomes in HIV-Infected Adults & Children
Scientific title: CIDRZ 1201 - Optimizing Clinical Outcomes in HIV-Infected Adults & Children Using Xpert MTB/RIF in Zambia
Date of first enrolment: August 2012
Target sample size: 1436
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02043080
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
Zambia
Contacts
Name:     Stewart Reid, MD
Address: 
Telephone:
Email:
Affiliation:  University of North Carolina
Key inclusion & exclusion criteria

Inclusion Criteria:

- Aged 15 years or above ("Adult"), or less than 15 years old ("Child") ;

- HIV-infected and enrolled in HIV care at Chongwe and Kafue District Hospitals

- Intends to continue receiving care at the district hospital for at least 6 months.

- TB suspects according to Zambian National Guidelines [31] ;

- Willing to provide signed informed consent (or parental consent, if the participant is
under 18);

- Willing (or parent or guardian willing) to provide locator information and allow
contact by phone or home visit

Exclusion Criteria:

- Diagnosed with TB within the last 6 months or taken TB treatment in the last 3 months

- Enrolled in another study which might interfere with study objectives (ex. TB-HAART)



Age minimum: N/A
Age maximum: 99 Years
Gender: All
Health Condition(s) or Problem(s) studied
HIV
Tuberculosis Diagnosis
Intervention(s)
Other: Xpert MTB/RIF Tuberculosis diagnostic tool
Primary Outcome(s)
Proportions of adult and paediatric patients receiving appropriate TB treatment in each study phase [Time Frame: within 4 weeks of initiation]
Secondary Outcome(s)
Clinical outcomes of subjects screened using the Xpert MTB/RIF algorithm compared to existing standard of care. [Time Frame: 3 and 6 months post TB-screening]
Secondary ID(s)
12-1402
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Centers for Disease Control and Prevention
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history